Atlas Trials

Enoxaparin 20mg Versus 30mg Subcutaneously Once Daily in Elderly Patients With Impaired Renal Function

Clinical trial NCT03158792 · COMPLETED

Trial details

NCT number
NCT03158792
Sponsor
Lebanese American University
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Venous ThromboembolismRenal Impairment
Start date
2015-10-24
Primary completion
2017-07-13
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.